...BRCA2 mutation had non-significant trend toward longer PFS compared to patients with unknown BRCA or BRCA1 mutation (20....
We earlier used PCR-dHPLC for mutation analysis of BRCA1 and BRCA2. In this article we report application of targeted re...
...BRCA2 and CDKN2A. Genetic risk assessment and testing is already available. Owing to limited experience worldwide, guida...
...BRCA2, we also compared variant interpretations in traditional reports to those produced using only non-proprietary reso...
...BRCA2 (BRCA1/2) mutations in clinic-based populations of Black women is limited. In order to address this gap, we perfor...
...BRCA2 (18% vs. 6% P = 0.09). HER2 gene amplification (17% vs. 4%, P < 0.001) and Her2/neu expression (10% vs. 2%, P < 0....
...BRCA2). The resulting diminished BRCA1/2 transcription not only leads to lower protein levels but also curtails the abil...
...BRCA2 families, mutation position did not significantly affect the OC risk (HR=1.50, 95%CI=0.74-3.04). However, in the B...
BRCA1 and BRCA2 mutation carriers have an increased risk of contralateral breast cancer after primary breast cancer. Ris...
...BRCA2 mutation carriers. In conclusion, the meta-analysis suggested that three SNPs in TOX3 were significantly associate...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269